Litigation Details for Pfizer Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2019)
✉ Email this page to a colleague
Pfizer Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-10-04 |
Court | District Court, D. Delaware | Date Terminated | 2021-06-29 |
Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | None | Referred To | |
Patents | 6,936,612; 7,208,489; 7,456,168 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Pfizer Inc. v. Mylan Pharmaceuticals Inc.
Details for Pfizer Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-04-29 | 1 | Exhibit A US Patent 6,936,612 B@, # 2 Exhibit B US Patent 7,208,489 B2, # 3 Exhibit C US Patent 7,456,168B2… to the expiration of U.S. Patent No. 6,936,612 ("the '612 patent"); … #: 2 U.S. Patent No. 7,208,489 ("the '489 patent"); and U.S. Patent No. 7,456,168 …;168 patent"). These three patents are referred to collectively herein as "the patents-in-suit…x27;489 patent, and/or validity of the '489 patent. The '489 patent claims, | External link to document | |
2020-07-24 | 87 | Notice of Service | Invalidity Contentions Regarding U.S. Patent Nos. RE47,739, 6,936,612, and 7,456,168 filed by Alembic Pharmacauticals…2019 29 June 2021 1:19-cv-01863 830 Patent None District Court, D. Delaware | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |